+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Bioscavenger therapy for organophosphate poisoning - an open-labeled pilot randomized trial comparing fresh frozen plasma or albumin with saline in acute organophosphate poisoning in humans

Bioscavenger therapy for organophosphate poisoning - an open-labeled pilot randomized trial comparing fresh frozen plasma or albumin with saline in acute organophosphate poisoning in humans

Clinical Toxicology 48(8): 813-819

Traditional treatment of organophosphate poisoning (OP) with oximes has had limited success. Fresh frozen plasma (FFP) or albumin, acting as bioscavengers to mop up free organophosphate, has been recently proposed as a treatment modality. In this pilot open-label, three-arm, randomized controlled study exploring proof of concept, we evaluated if bioscavenger therapy had a role in OP. Sixty patients with significant poisoning presenting within 12 hours, with suppression of pseudocholinesterase activity to < 1,000 U/L, were randomized to receive FFP (8 bags, 250 mL each over 3 days), 20% human albumin (4 × 100 mL over 3 days), or saline (2,000 mL over 3 days) in addition to atropine and supportive care. Pseudocholinesterase and organophosphate levels were measured pretreatment, post-infusion (Day 2, Day 3), and predischarge and expressed as mean ± standard error. The incidence of intermediate syndrome, need for mechanical ventilation, atropine requirement, and mortality were assessed. Twenty patients received albumin and 19 patients each FFP or saline. FFP increased pseudocholinesterase levels (250 ± 44-1,241 ± 364 U/L) significantly (p = 0.007). Small, nonsignificant increases were observed with saline (160 ± 30-259 ± 78) and albumin (146 ± 18-220 ± 61). Organophosphate levels reduced in all 3 arms; no clear-cut trends were observed. We observed more cases of intermediate syndrome with FFP [10/19 (53%) vs. 5/20 (25%) vs. 5/19 (26%), FFP, albumin, and saline arms (p = 0.15)]. The interventions did not affect ventilatory requirements (14/19 vs. 15/20 vs. 14/19) or prevent delayed intubation. There were no differences in mean (±standard error) atropine requirement (in milligrams) in the first 3 days (536 ± 132 vs. 361 ± 125 vs. 789 ± 334) and duration (in days) of ventilation (10.0 ± 2.1 vs. 7.1 ± 1.5 vs. 7.5 ± 1.5) or hospital stay (12.4 ± 2.2 vs. 9.8 ± 1.4 vs. 9.8 ± 1.6). Two patients developed adverse effects with FFP. Mortality was similar (4/19 vs. 5/20 vs. 2/19, p = 0.6). Despite significant increase in pseudocholinesterase levels with FFP, this pilot study did not demonstrate favorable trends in clinical outcomes with FFP or albumin.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 051820155

Download citation: RISBibTeXText

PMID: 20923392

DOI: 10.3109/15563650.2010.518970

Related references

Fresh frozen plasma as a successful antidotal supplement in acute organophosphate poisoning. Arhiv Za Higijenu Rada i Toksikologiju 64(2): 87-91, 2013

Effectiveness of fresh frozen plasma as supplementary treatment in organophosphate poisoning. Medical Journal of Malaysia 66(4): 342-345, 2011

The effects of fresh frozen plasma on cholinesterase levels and outcomes in patients with organophosphate poisoning. Journal of Toxicology, Clinical Toxicology 42(5): 617-623, 2004

Effects of acute organophosphate poisoning on pituitary target gland hormones at admission, discharge and three months after poisoning: A hospital based pilot study. Indian Journal of Endocrinology and Metabolism 19(1): 116-123, 2015

Early hypocaloric enteral nutritional supplementation in acute organophosphate poisoning--a prospective randomized trial. Clinical Toxicology 47(5): 419-424, 2009

Open-label randomized clinical trial of atropine bolus injection versus incremental boluses plus infusion for organophosphate poisoning in Bangladesh. Journal of Medical Toxicology 8(2): 108-117, 2012

Preparation and characterization of methoxy polyethylene glycol-conjugated phosphotriesterase as a potential catalytic bioscavenger against organophosphate poisoning. Chemico-Biological Interactions 187(1-3): 380-383, 2010

Delayed-onset encephalopathy and coma in acute organophosphate poisoning in humans. Neurotoxicology 29(2): 335-342, 2008

Organophosphate poisoning. Effects of selected organophosphate pesticides on plasma enzymes and brain esterases of Japanese quail (Coturnix coturnix japonica). Journal of Agricultural and Food Chemistry 29(4): 772-778, 1981

Poisoning severity score, Glasgow coma scale, corrected QT interval in acute organophosphate poisoning. Human and Experimental Toxicology 29(5): 419-425, 2010

Treatment of organophosphate poisoning. Experience of nerve agents and acute pesticide poisoning on the effects of oximes. Journal of Physiology Paris 92(5-6): 375-378, 1998

Management of acute endosulfan poisoning in an organophosphate poisoning clinic. Clinical Toxicology 45(5): 563-564, 2007

Lipid emulsion for acute organophosphate insecticide poisoning - a pilot observational safety study. Clinical Toxicology 57(5): 318-324, 2019

Adjuncts and alternatives to oxime therapy in organophosphate poisoning--is there evidence of benefit in human poisoning? A review. Anaesthesia and Intensive Care 36(3): 339-350, 2008

Prompt recovery from severe cholinesterase-inhibitor poisoning - remarks on classification and therapy of organophosphate poisoning. Klinische Wochenschrift 68(12): 615-618, 1990